Osaic Holdings’s Pacer BioThreat Strategy ETF VIRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,007
| Closed | -$359K | – | 7757 |
|
|
2024
Q3 | $359K | Hold |
9,007
| – | – | ﹤0.01% | 3172 |
|
|
2024
Q2 | $327K | Buy |
9,007
+55
| +0.6% | +$1.96K | ﹤0.01% | 3128 |
|
|
2024
Q1 | $324K | Sell |
8,952
-459
| -5% | -$15.8K | ﹤0.01% | 3281 |
|
|
2023
Q4 | $304K | Sell |
9,411
-2,735
| -23% | -$82.3K | ﹤0.01% | 3588 |
|
|
2023
Q3 | $362K | Sell |
12,146
-355
| -3% | -$11.1K | ﹤0.01% | 3523 |
|
|
2023
Q2 | $390K | Sell |
12,501
-96
| -0.8% | -$2.86K | ﹤0.01% | 3353 |
|
|
2023
Q1 | $369K | Sell |
12,597
-863
| -6% | -$24.7K | ﹤0.01% | 3365 |
|
|
2022
Q4 | $380K | Sell |
13,460
-71
| -0.5% | -$1.96K | ﹤0.01% | 3278 |
|
|
2022
Q3 | $340K | Sell |
13,531
-46,451
| -77% | -$1.28M | ﹤0.01% | 3265 |
|
|
2022
Q2 | $1.59M | Sell |
59,982
-849
| -1% | -$24.2K | ﹤0.01% | 1835 |
|
|
2022
Q1 | $1.88M | Buy |
60,831
+777
| +1% | +$24.2K | ﹤0.01% | 1968 |
|
|
2021
Q4 | $2.09M | Buy |
60,054
+55,530
| +1,227% | +$1.89M | ﹤0.01% | 1747 |
|
|
2021
Q3 | $147K | Buy |
4,524
+2,567
| +131% | +$85.3K | ﹤0.01% | 4198 |
|
|
2021
Q2 | $62K | Hold |
1,957
| – | – | ﹤0.01% | 4884 |
|
|
2021
Q1 | $56K | Buy |
1,957
+133
| +7% | +$3.85K | ﹤0.01% | 4812 |
|
|
2020
Q4 | $51K | Buy |
1,824
+531
| +41% | +$14.9K | ﹤0.01% | 4556 |
|
|
2020
Q3 | $36K | Buy |
+1,293
| New | +$34.8K | ﹤0.01% | 4542 |
|
Osaic Holdings's VIRS Position: Q4 2024 in Review
Osaic Holdings sold out of Pacer BioThreat Strategy ETF (VIRS) in Q4 2024, closing a stake of 9,007 shares — an estimated $359K sold.
Osaic Holdings first reported a position in VIRS in Q3 2020 and held it in 17 quarters. The position peaked at $2.09M in Q4 2021. 0 funds tracked by Wall St. Rank hold VIRS as of Q4 2024.
- Osaic Holdings reported no remaining Pacer BioThreat Strategy ETF position as of Q4 2024 after selling out during the quarter.
- Osaic Holdings sold 9,007 Pacer BioThreat Strategy ETF shares in Q4 2024, an estimated $359K.
- Osaic Holdings first reported a position in Pacer BioThreat Strategy ETF in Q3 2020 and held it in 17 quarters.
- Osaic Holdings's Pacer BioThreat Strategy ETF position peaked at $2.09M in Q4 2021.
- 0 funds tracked by Wall St. Rank held Pacer BioThreat Strategy ETF as of Q4 2024.
Based on Osaic Holdings's 13F filing for Q4 2024, filed 7 Feb 2025.